Cancer Institute A national cancer institute
designated cancer center

October 2010 Cancer Center Bulletin

Director's Message

Dear Cancer Center members,

NCI center designation renewed

I am delighted to report that the Stanford Cancer Center has received a five-year renewal as a National Cancer Institute-designated cancer center, an honor that recognizes us for scientific and clinical excellence. Along with the designation, the Cancer Center will receive $17 million over the next five years. We particularly thank Dean Pizzo for his exceptional support in this endeavor and look forward to five years of exciting scientific discovery and advances in patient care. Integral to our mission is the enhancement of our interdisciplinary approaches to cancer prevention, diagnosis and treatment, and we will look to the Cancer Center membership to help make this happen with whatever support we can provide.

Cancer Center moves to Lorry Lokey Building

The Stanford Cancer Center has a new home. On Sept. 20, 2010, we moved into the recently completed Lorry Lokey Building on Campus Drive and Welch Road. Our 14,150-nasf space on the second floor of the building includes the Cancer Center’s administrative offices, five laboratory groups and 72 laboratory benches.

The Lokey Building, as many of you know, was funded in part by the California Institute of Regenerative Medicine and in part by the generous gift of Lorry Lokey as well as other wonderful donors. It was designed to inspire and nurture scientific advances relevant to stem cell and cancer stem cell research that translates quickly from basic research to clinical application. We have assigned “hotel benches,” where visiting investigators with interests in stem cell or cancer stem cell research can collaborate with others in the building for periods of one to three years. I invite all members of the Stanford Cancer Center to visit us and tour the new building.

Tseng Lecture

On November 17, at 4 pm, Nobel Laureate Harald zur Hausen, MD, will present the Fourth Annual Cynthia and Alexander Tseng, Jr, MD, Lecture in the Braun Auditorium in the Keck Chemistry Building. Dr. zur Hausen received the 2008 Nobel Prize in Physiology or Medicine for his discovery of human papilloma viruses as a cause of cervical cancer. His research made it possible to develop a vaccine against the third most frequent kind of cancer affecting women.

Core Facilities

One of our major roles is to help provide outstanding core facilities for our members. Please visit the website (cancer.stanford.edu) or pick up a leaflet at the CC administrative office for an updated list of core services which CC members receive at a discount.

Kudos

Sam (Sanjiv) Gambhir, MD, PhD, Virginia & D.K. Ludwig Professor of Radiology & Bioengineering , director of the Molecular Imaging Program at Stanford and the Canary Center at Stanford for Cancer Early Detection, has received three five-year grants from the National Cancer Institute that total more than $28 million.

About $25 million will be used over the coming five years to fund two centers at Stanford that will develop new diagnostic techniques and therapies, as well as advance the understanding of basic cancer cell biology.

The first grant, totaling nearly $10 million, will help support the In Vivo Cellular and Molecular Imaging Center at Stanford, or ICMIC, which implements state-of-the-art molecular imaging strategies to facilitate new cancer research and improve care of cancer patients. The award will fund several research projects involving positron emission tomography, magnetic resonance and optical imaging.

The co-principal investigator on this project is Christopher Contag, PhD, associate professor of pediatrics and of microbiology and immunology.

The second grant, of about $15 million, will fund the Center for Cancer Nanotechnology Excellence and Translation, or CCNE-T, which, like the ICMIC, fosters interdisciplinary work. Faculty from radiology, bioengineering, materials science, oncology and other departments collaborate in the center’s effort to use and develop nanotechnology to improve cancer-patient management by, for instance, promoting earlier cancer detection and better monitoring of responses to anti-cancer therapy.

Sam also received a $3 million NCI-sponsored Early Detection Research Network (EDRN) Biomarker Development Laboratory (BDL) Grant. The intent of the EDRN BDL Project is to first outline the adaptation of the newly developed magneto-nano sensor for the multiplex of blood biomarkers for prostate cancer detection and prognostication (in vitro), then to subsequently propose the adaptation of the latest ultrasound technology using tumor angiogenesis-targeted microbubbles to image prostate cancer (in vivo).

James Brooks, MD, associate professor of urology, is co-principal investigator on the project. Other members of the interdisciplinary research team are Jessey McKenney, MD, in pathology, Shan Wang, PhD, in materials science and engineering, and Juergen Willmann, MD, in radiology.

Samuel So, MD, Lui Hac Minh Professor and director of the Asian Liver Center, was honored by the Centers for Disease Control Prevention, the Agency for Toxic Substances and Disease Registry and the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention for his pioneering efforts to mobilize people and resources in ways that have changed global public health policies related to hepatitis B, saving lives and increasing productivity.

Please let us know of new grants, honors, and publications so that we can include them in the monthly Bulletin.


Best regards,

Bev

Beverly Mitchell Signature
Beverly S. Mitchell, MD
Director, Stanford Cancer Center

(August 2010 Director's Message)

Posted 10/06/10

Stanford Medicine Resources:

Footer Links: